Dr. Horst G. Zerbe

IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) reported its financial results late Thursday for the third quarter that ended September 30, 2022. Dr. Horst G. Zerbe, CEO of IntelGenx called the third quarter a “productive one” for IntelGenx, marked by the achievement of...

IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, reported financial results on Thursday afternoon for the third quarter ended September 30, 2021. 2021 Third Quarter Financial Summary...